Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 9.055 |
|
|||||
| News | (1) | ||||||
| Tageshoch | 4,8279 | Niedrig Hoch |
|||||
| Tagestief | 4,61 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Lipocine Inc | LPCN | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,09 | 1,95% | 4,71 | 00:55:13 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 4,65 | 4,61 | 4,8279 | 4,71 | 4,62 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 165 | 9.055 | US$ 4,71 | US$ 42.675 | - | 2,3101 - 7,15 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:59:04 | 2 | US$ 4,83 | USD |
Finanzwerte LPCN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 25,04M | 5,32M | - | -2,85M | -16,35M | -3,08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Lipocine
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 01.5.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Completion of Dosing in Pivotal Study of.. |
| 11.4.2024 | 13:00 | PR Newswire (US) | Lipocine Announces Positive LPCN 2401 Clinical Results.. |
| 28.3.2024 | 13:00 | PR Newswire (US) | Lipocine Announces Positive Week 52 Results from LPCN 1148.. |
| 25.3.2024 | 13:00 | PR Newswire (US) | Lipocine Announces First Cohort Dosed in Pivotal Study of.. |
| 07.3.2024 | 23:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Financial Results for the Full Year Ended.. |
| 07.3.2024 | 12:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 12:07 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 06.3.2024 | 14:00 | PR Newswire (US) | Lipocine to Present at 36th Annual Roth Conference |
| 06.3.2024 | 12:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12.2.2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.2.2024 | 14:00 | PR Newswire (US) | Lipocine Announces Confirmation of Dosing Regimen for.. |
Forum Lipocine
Keine Diskussionen Gefunden.Neuen Thread Erstellen
LPCN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 4,79 | 5,02 | 4,38 | 4,58 | 30.299 | -0,08 | -1,67% |
| 1 Monat | 5,00 | 7,15 | 4,38 | 6,09 | 150.489 | -0,29 | -5,80% |
| 3 Monate | 4,06 | 7,15 | 3,20 | 5,70 | 67.104 | 0,65 | 16,01% |
| 6 Monate | 2,52 | 7,15 | 2,35 | 4,96 | 45.809 | 2,19 | 86,90% |
| 1 Jahr | 4,42 | 7,15 | 2,3101 | 4,84 | 89.341 | 0,29 | 6,56% |
| 3 Jahre | 24,14 | 32,13 | 2,3101 | 18,27 | 372.509 | -19,43 | -80,49% |
| 5 Jahre | 31,79 | 59,50 | 2,3101 | 23,43 | 975.525 | -27,08 | -85,18% |
